CUSIP 61225M102 · who reports it, how much, and how much it matters to them
24 of the 720 hedge fund managers we track reported shares of Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE) on Form 13F for 30 June 2026. Between them they reported USD 355m. The largest position belongs to Baker Bros. Advisors, at USD 105m. The manager with the most riding on it is Boone Capital Management, where it is 3.5% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Baker Bros. Advisors2 funds on PPLI.com | USD 105m | 0.5% |
| 2 | Suvretta Capital Management4 funds on PPLI.com | USD 86m | 1.6% |
| 3 | Braidwell12 funds on PPLI.com | USD 59m | 2.2% |
| 4 | Marshall Wace LLP84 funds on PPLI.com | USD 39m | 0.0% |
| 5 | Boone Capital Management1 fund on PPLI.com | USD 15m | 3.5% |
| 6 | Adage Capital Management1 fund on PPLI.com | USD 11m | 0.0% |
| 7 | Balyasny Asset Management25 funds on PPLI.com | USD 4.8m | 0.0% |
| 8 | Casdin Capital3 funds on PPLI.com | USD 4.5m | 0.2% |
| 9 | D. E. Shaw & Co.15 funds on PPLI.com | USD 4.2m | 0.0% |
| 10 | Citadel Advisors32 funds on PPLI.com | USD 4m | 0.0% |
| 11 | Two Sigma Investments35 funds on PPLI.com | USD 3.4m | 0.0% |
| 12 | Exome Asset Management2 funds on PPLI.com | USD 3.3m | 2.0% |
| 13 | Exoduspoint Capital Management7 funds on PPLI.com | USD 2.9m | 0.0% |
| 14 | Atom Investors1 fund on PPLI.com | USD 2.7m | 0.2% |
| 15 | Jain Global1 fund on PPLI.com | USD 2.7m | 0.0% |
| 16 | Renaissance Technologies13 funds on PPLI.com | USD 2.5m | 0.0% |
| 17 | Squarepoint Ops7 funds on PPLI.com | USD 2m | 0.0% |
| 18 | Persistent Asset Partners10 funds on PPLI.com | USD 825,000 | 0.2% |
| 19 | Aquatic Capital Management3 funds on PPLI.com | USD 739,000 | 0.0% |
| 20 | Campbell & Company Investment Adviser8 funds on PPLI.com | USD 687,000 | 0.0% |
| 21 | Verition Fund Management3 funds on PPLI.com | USD 496,000 | 0.0% |
| 22 | J. Goldman & Co.1 fund on PPLI.com | USD 366,000 | 0.0% |
| 23 | Mangrove Partners Im1 fund on PPLI.com | USD 303,000 | 0.0% |
| 24 | The Quarry1 fund on PPLI.com | USD 1,621 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Boone Capital Management | USD 15m | 3.5% |
| 2 | Braidwell | USD 59m | 2.2% |
| 3 | Exome Asset Management | USD 3.3m | 2.0% |
| 4 | Suvretta Capital Management | USD 86m | 1.6% |
| 5 | Baker Bros. Advisors | USD 105m | 0.5% |
| 6 | Persistent Asset Partners | USD 825,000 | 0.2% |
| 7 | Atom Investors | USD 2.7m | 0.2% |
| 8 | Casdin Capital | USD 4.5m | 0.2% |
| 9 | Campbell & Company Investment Adviser | USD 687,000 | 0.0% |
| 10 | Marshall Wace LLP | USD 39m | 0.0% |
Monte Rosa Therapeutics, Inc. trades under the symbol GLUE on the Nasdaq. Its CUSIP, the code used on Form 13F, is 61225M102.
24 of the 720 hedge fund managers PPLI.com tracks reported Monte Rosa Therapeutics, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Baker Bros. Advisors (USD 105m), Suvretta Capital Management (USD 86m), Braidwell (USD 59m), Marshall Wace LLP (USD 39m) and Boone Capital Management (USD 15m).
24 managers in our coverage reported it, and between them they run 272 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Boone Capital Management, where the position was 3.5% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Monte Rosa Therapeutics, Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.